Dr Jennifer Michelle Pugliese, MD | |
300 W Hospital Rd, Fort Gordon, GA 30905-5741 | |
(706) 787-2862 | |
Not Available |
Full Name | Dr Jennifer Michelle Pugliese |
---|---|
Gender | Female |
Speciality | Urology |
Location | 300 W Hospital Rd, Fort Gordon, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710959689 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 23111 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jennifer Michelle Pugliese, MD 300 Hospital Road, Urology Clinic, Apo, AA 30905-5650 Ph: () - | Dr Jennifer Michelle Pugliese, MD 300 W Hospital Rd, Fort Gordon, GA 30905-5741 Ph: (706) 787-2862 |
News Archive
Pasteurized human milk is a recommended alternative for hospitalized sick newborns when their own mother's milk is not available, according to a new statement by the Canadian Paediatric Society. The statement, published today in Paediatrics & Child Health, says that human milk banking in Canada should be encouraged and promoted.
The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).
Researchers at the University of Warwick's Warwick Medical School have uncovered a process that locks the body's metabolism in a diabetic state after only relatively limited exposure to high glucose levels.
Eisai Inc. announced today that the Phase III ACCESS (A Controlled Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial of the investigational compound eritoran (E5564) will continue enrolling to the preset goal of 2,000 patients. As part of a planned interim analysis, an independent Data Monitoring Committee (DMC) has evaluated efficacy and safety data on the first 1,500 subjects to complete the 28-day follow-up in the Phase III ACCESS trial.
› Verified 6 days ago
Dr. Aaron William Brothers, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 300 E Hospital Rd, Ddeamc, Fort Gordon, GA 30905 Phone: 706-787-3116 |